%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Kelly M. Hennessey, Ilse C. Rogiers, Han-Wei Shih, Matthew A. Hulverson, Ryan Choi, Molly C. McCloskey, Grant R. Whitman, Lynn K. Barrett, Ethan A. Merritt, Alexander R. Paredez, Kayode K. Ojo
Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum
www.plosntds.org
www.plosntds.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref006)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref007)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref008)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref009)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref011)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref014)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref015)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref016)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref018)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref019)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref020)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref021)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref022)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref023)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref024)>>
endobj
38 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006673.ref025)>>
endobj
39 0 obj
<>/Border[0 0 0]/A 40 0 R>>
endobj
40 0 obj
<>
endobj
15 0 obj
[41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R]
endobj
41 0 obj
<>stream
q
0.955 g
0 w
199.9998 713.9999 m
575.9997 713.9999 l
575.9997 481.0005 l
199.9998 481.0005 l
f*
0.83 0.64 0.02 0 k
260.2205 393.9024 m
264.9827 393.9024 l
h
f*
269.4047 393.9024 m
274.1669 393.9024 l
h
f*
340.3276 341.915 m
345.0898 341.915 l
h
f*
349.5685 341.915 m
354.3307 341.915 l
h
f*
282.274 328.9323 m
287.0362 328.9323 l
h
f*
402.4063 315.9496 m
407.1685 315.9496 l
h
f*
411.5906 315.9496 m
416.3528 315.9496 l
h
f*
316.9701 276.9449 m
321.7323 276.9449 l
h
f*
326.211 276.9449 m
330.9732 276.9449 l
h
f*
243.1559 250.9228 m
247.9181 250.9228 l
h
f*
252.3402 250.9228 m
261.8646 250.9228 l
h
f*
418.6772 237.9402 m
428.2016 237.9402 l
h
f*
433.3606 237.9402 m
442.885 237.9402 l
h
f*
305.2346 211.9181 m
314.7024 211.9181 l
h
f*
227.3953 198.9354 m
236.9197 198.9354 l
h
f*
242.0787 198.9354 m
251.6031 198.9354 l
h
f*
510.8598 185.8961 m
520.3276 185.8961 l
h
f*
401.6693 172.9134 m
411.1937 172.9134 l
h
f*
499.8047 159.9307 m
509.3291 159.9307 l
h
f*
278.022 94.9039 m
287.5465 94.9039 l
h
f*
291.9685 94.9039 m
301.4929 94.9039 l
h
f*
376.0441 81.9213 m
385.5685 81.9213 l
h
f*
557.0646 81.9213 m
566.5323 81.9213 l
h
f*
0 g
1 j
1 J
10 0 0 10 209.9905 696.9826 cm
BT
/F9 1 Tf
1 TL
0.005 Tc
0 0 Td
(diseases)Tj
3.4525 0 Td
(are)Tj
1.474 0 Td
(significant)Tj
4.4901 0 Td
(public)Tj
2.7609 0 Td
(health)Tj
2.7326 0 Td
(challenges)Tj
4.405 0 Td
(for)Tj
1.4173 0 Td
(which)Tj
2.6929 0 Td
(there)Tj
2.3074 0 Td
(are)Tj
1.4797 0 Td
(limited)Tj
3.1294 0 Td
(available)Tj
-30.3418 -1.2982 Td
(remedies.)Tj
4.1442 0 Td
(An)Tj
1.4683 0 Td
(effective)Tj
3.5943 0 Td
(drug)Tj
2.1487 0 Td
(developed)Tj
4.3483 0 Td
(based)Tj
2.5228 0 Td
(on)Tj
1.2926 0 Td
(phenotypic)Tj
4.7905 0 Td
(properties)Tj
4.371 0 Td
(against)Tj
/F14 1 Tf
3.0898 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.1395 0 Td
[()4()16()]TJ
-32.91 -1.2983 Td
[()10()12()4()]TJ
/F9 1 Tf
1.7234 0 Td
(and)Tj
/F14 1 Tf
1.7575 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.0828 0 Td
[( )4()16(\n)-20()-13()12()]TJ
/F9 1 Tf
3.3335 0 Td
(would)Tj
2.761 0 Td
(likely)Tj
2.4094 0 Td
(have)Tj
2.0919 0 Td
(some)Tj
2.3698 0 Td
(impact)Tj
3.033 0 Td
(on)Tj
1.2926 0 Td
(other)Tj
2.3925 0 Td
(diarrheal)Tj
3.9061 0 Td
(parasites)Tj
3.7644 0 Td
(and)Tj
1.7574 0 Td
(be)Tj
-33.6753 -1.3039 Td
(useful)Tj
2.6475 0 Td
(as)Tj
1.0318 0 Td
(a)Tj
0.6633 0 Td
(prophylactic)Tj
5.3178 0 Td
(indication)Tj
4.3993 0 Td
(against)Tj
3.0897 0 Td
(asymptomatic)Tj
5.9641 0 Td
(diseases.)Tj
3.685 0 Td
(An)Tj
1.4684 0 Td
(important)Tj
4.3653 0 Td
(step)Tj
-32.6322 -1.2983 Td
(towards)Tj
3.4695 0 Td
(this)Tj
1.7065 0 Td
(goal)Tj
1.9105 0 Td
(is)Tj
0.8674 0 Td
(the)Tj
1.4967 0 Td
(use)Tj
1.559 0 Td
(of)Tj
1.0318 0 Td
(fast)Tj
1.6328 0 Td
(and)Tj
1.7575 0 Td
(inexpensive)Tj
5.0229 0 Td
(methods)Tj
3.7474 0 Td
(to)Tj
1.0431 0 Td
(identify)Tj
3.3676 0 Td
(new)Tj
1.8992 0 Td
(potential)Tj
-30.5119 -1.2982 Td
(drug)Tj
2.1486 0 Td
(candidates.)Tj
4.7905 0 Td
(Among)Tj
3.2882 0 Td
(the)Tj
1.4967 0 Td
(goals)Tj
2.279 0 Td
(of)Tj
1.0318 0 Td
(this)Tj
1.7121 0 Td
(study)Tj
2.4321 0 Td
(is)Tj
0.8674 0 Td
(the)Tj
1.4967 0 Td
(design)Tj
2.8687 0 Td
(of)Tj
1.0318 0 Td
(an)Tj
1.2189 0 Td
(efficient)Tj
3.5262 0 Td
(biolumines-)Tj
-30.1887 -1.3039 Td
(cent)Tj
1.9502 0 Td
(assay)Tj
2.3074 0 Td
(that)Tj
1.8198 0 Td
(can)Tj
1.6497 0 Td
(be)Tj
1.1679 0 Td
(used)Tj
2.0976 0 Td
(to)Tj
1.0432 0 Td
(measure)Tj
3.6453 0 Td
(growth)Tj
3.1238 0 Td
(inhibition)Tj
4.3143 0 Td
(of)Tj
/F14 1 Tf
1.0374 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.1339 0 Td
[()4()16()17()10()12()4()]TJ
/F9 1 Tf
3.2485 0 Td
(trophozoites)Tj
5.3234 0 Td
(in)Tj
-33.8624 -1.2983 Td
(an)Tj
1.2188 0 Td
(efficient,)Tj
3.7644 0 Td
(high-throughput)Tj
7.0639 0 Td
(screen)Tj
2.8233 0 Td
(of)Tj
1.0318 0 Td
(large)Tj
2.2054 0 Td
(compound)Tj
4.6714 0 Td
(libraries.)Tj
3.7814 0 Td
(Stable)Tj
2.6589 0 Td
(expression)Tj
4.5581 0 Td
(of)Tj
-33.7774 -1.2983 Td
(the)Tj
1.4966 0 Td
(luciferase)Tj
4.0762 0 Td
(gene)Tj
2.1147 0 Td
(introduced)Tj
4.7338 0 Td
(into)Tj
/F14 1 Tf
1.8765 0 Td
[()13()4()16(\n)20(\r)12()4()]TJ
/F9 1 Tf
3.3222 0 Td
(was)Tj
1.7235 0 Td
(observed)Tj
3.8721 0 Td
(over)Tj
2.0069 0 Td
(a)Tj
0.6633 0 Td
(24-hour)Tj
3.5206 0 Td
(incubation)Tj
-29.4064 -1.2982 Td
(period.)Tj
3.1237 0 Td
(The)Tj
1.8085 0 Td
(assay)Tj
2.3074 0 Td
(was)Tj
1.7291 0 Td
(validated)Tj
3.9118 0 Td
(for)Tj
1.4173 0 Td
(reproducibility)Tj
6.3269 0 Td
(and)Tj
1.7575 0 Td
(reliability)Tj
4.1045 0 Td
(against)Tj
3.0898 0 Td
(known)Tj
/F14 1 Tf
3.05 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.1339 0 Td
[()4()16()]TJ
-33.7604 -1.304 Td
[()10()12()4()]TJ
/F9 1 Tf
1.7234 0 Td
(drugs)Tj
2.5172 0 Td
(with)Tj
2.0295 0 Td
(the)Tj
1.4967 0 Td
(obtained)Tj
3.8098 0 Td
(EC)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 338.2299 565.3417 cm
BT
/F9 1 Tf
1 TL
0.0067 Tc
0 0 Td
(50)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 347.7543 566.9858 cm
BT
/F9 1 Tf
1 TL
0.005 Tc
0 0 Td
(values)Tj
2.7212 0 Td
(within)Tj
2.863 0 Td
(a)Tj
0.6633 0 Td
(statistically)Tj
4.7281 0 Td
(acceptable)Tj
4.4391 0 Td
(range,)Tj
2.7439 0 Td
(com-)Tj
-31.9348 -1.2982 Td
(pared)Tj
2.5398 0 Td
(to)Tj
1.0431 0 Td
(literature)Tj
3.9685 0 Td
(values.)Tj
2.9594 0 Td
(A)Tj
0.9127 0 Td
(test)Tj
1.6384 0 Td
(of)Tj
1.0317 0 Td
(the)Tj
1.4967 0 Td
(high-throughput)Tj
7.0582 0 Td
(drug)Tj
2.1487 0 Td
(screening)Tj
4.1329 0 Td
(capability)Tj
4.1612 0 Td
(of)Tj
1.0318 0 Td
(the)Tj
-34.1231 -1.2983 Td
(assay)Tj
2.313 0 Td
(was)Tj
1.7235 0 Td
(verified)Tj
3.3165 0 Td
(in)Tj
1.0545 0 Td
(a)Tj
0.6576 0 Td
(parallel)Tj
3.2145 0 Td
(screen)Tj
2.8232 0 Td
(of)Tj
/F14 1 Tf
1.0318 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.1395 0 Td
[()4()16()17()10()12()4()]TJ
/F9 1 Tf
3.2485 0 Td
(and)Tj
/F14 1 Tf
1.7574 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.0829 0 Td
[( )4()16(\n)-20()-13()12()]TJ
/F9 1 Tf
3.3335 0 Td
(with)Tj
2.0352 0 Td
(the)Tj
1.4967 0 Td
(aim)Tj
1.7688 0 Td
(of)Tj
1.0318 0 Td
(find-)Tj
-33.0289 -1.3039 Td
(ing)Tj
1.5307 0 Td
(potential)Tj
3.838 0 Td
(dual)Tj
1.9956 0 Td
(pathogen-inhibiting)Tj
8.4244 0 Td
(molecules.)Tj
4.5128 0 Td
(Seven)Tj
2.5908 0 Td
(compounds)Tj
5.04 0 Td
(inhibited)Tj
3.9344 0 Td
(both)Tj
2.0977 0 Td
(par-)Tj
-33.9644 -1.2983 Td
(asites)Tj
2.4207 0 Td
(at)Tj
0.9695 0 Td
(low)Tj
1.6837 0 Td
(micromolar)Tj
5.074 0 Td
(levels)Tj
2.4321 0 Td
(as)Tj
1.0318 0 Td
(confirmed)Tj
4.4787 0 Td
(by)Tj
1.1962 0 Td
(follow)Tj
2.7552 0 Td
(up)Tj
1.2813 0 Td
(assays.)Tj
2.914 0 Td
(This)Tj
2.0239 0 Td
(series)Tj
2.4831 0 Td
(of)Tj
1.0318 0 Td
(inhibitors)Tj
-31.776 -1.2982 Td
(could)Tj
2.5001 0 Td
(be)Tj
1.1679 0 Td
(further)Tj
3.0897 0 Td
(developed)Tj
4.354 0 Td
(as)Tj
1.0318 0 Td
(therapeutics)Tj
5.1986 0 Td
(and)Tj
1.7575 0 Td
(potentially)Tj
4.5637 0 Td
(become)Tj
3.3732 0 Td
(an)Tj
1.2246 0 Td
(important)Tj
4.3597 0 Td
(new)Tj
-32.6208 -1.3039 Td
(tool)Tj
1.8141 0 Td
(for)Tj
1.4117 0 Td
(giardiasis)Tj
4.0705 0 Td
(and)Tj
1.7518 0 Td
(cryptosporidiosis)Tj
7.2622 0 Td
(treatments.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 438.0094 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 421.0015 cm
BT
/F14 1 Tf
1 TL
-0.004 Tc
0 0 Td
[()13(\n)-20()-13( )12()11()7()10( )4()11(\n)-9()4(\r)12()12()12()]TJ
/F9 1 Tf
6.8427 0 Td
(and)Tj
/F14 1 Tf
1.7292 0 Td
[()13()4()16(\n)20(\r)12()4()]TJ
/F9 1 Tf
3.2598 0 Td
(are)Tj
1.4456 0 Td
(widely)Tj
2.8233 0 Td
(acknowledged)Tj
5.9301 0 Td
(as)Tj
1.0148 0 Td
(significant)Tj
4.388 0 Td
(waterborne)Tj
4.7848 0 Td
(pathogens,)Tj
4.5298 0 Td
(as)Tj
-36.7481 -1.2982 Td
(both)Tj
2.0579 0 Td
(are)Tj
1.4513 0 Td
(major)Tj
2.6079 0 Td
(contributors)Tj
5.2044 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(global)Tj
2.6249 0 Td
(health)Tj
2.6758 0 Td
(burden)Tj
3.1238 0 Td
(of)Tj
1.0148 0 Td
(diarrheal)Tj
3.8268 0 Td
(diseases)Tj
3.3788 0 Td
(in)Tj
1.0318 0 Td
(children)Tj
3.5547 0 Td
(under)Tj
-35.053 -1.3039 Td
(the)Tj
1.4683 0 Td
(age)Tj
1.542 0 Td
(of)Tj
1.0148 0 Td
(five)Tj
1.6554 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(2)Tj
0 g
(].)Tj
1.2643 0 Td
(Since)Tj
/F14 1 Tf
2.3584 0 Td
[()13()4()16(\n)20(\r)12()4()]TJ
/F9 1 Tf
3.2541 0 Td
(and)Tj
/F14 1 Tf
1.7291 0 Td
[()13(\n)-20()-13( )12()11()7()10( )4()11(\n)-9()4(\r)12()12()12()]TJ
/F9 1 Tf
6.8428 0 Td
(infections)Tj
4.1556 0 Td
(are)Tj
1.4457 0 Td
(among)Tj
2.999 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
2.2054 0 Td
(com-)Tj
-34.6618 -1.2983 Td
(mon)Tj
2.0919 0 Td
(cause)Tj
2.3924 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0728 0 Td
(and)Tj
1.7348 0 Td
(asymptomatic)Tj
5.8506 0 Td
(parasitic)Tj
3.5943 0 Td
(diseases)Tj
3.3789 0 Td
(in)Tj
1.0375 0 Td
(children)Tj
3.5546 0 Td
(in)Tj
1.0375 0 Td
(resource-limited)Tj
-28.7601 -1.2983 Td
(environments,)Tj
6.015 0 Td
(a)Tj
0.6577 0 Td
(new)Tj
1.8708 0 Td
(dual)Tj
2.3528 0 Td
(use)Tj
1.9218 0 Td
(therapeutic)Tj
4.7339 0 Td
(would)Tj
2.7099 0 Td
(be)Tj
1.1508 0 Td
(a)Tj
0.6577 0 Td
(very)Tj
1.9218 0 Td
(valuable)Tj
3.4923 0 Td
(treatment)Tj
4.1386 0 Td
(option.)Tj
/F14 1 Tf
3.0897 0 Td
[()13()4()16(\n)19()]TJ
-34.7128 -1.3039 Td
[(\r)12()4()]TJ
/F9 1 Tf
1.4683 0 Td
(replicates)Tj
3.9855 0 Td
(through)Tj
3.4469 0 Td
(binary)Tj
2.8006 0 Td
(fission)Tj
2.8176 0 Td
(and)Tj
1.7348 0 Td
(colonizes)Tj
3.9118 0 Td
(the)Tj
1.474 0 Td
(small)Tj
2.3244 0 Td
(intestine)Tj
3.6567 0 Td
(of)Tj
1.0148 0 Td
(vertebrate)Tj
4.2236 0 Td
(hosts)Tj
2.279 0 Td
(by)Tj
-35.138 -1.2982 Td
(attachment)Tj
4.7224 0 Td
(through)Tj
3.4469 0 Td
(a)Tj
0.652 0 Td
(ventral)Tj
2.999 0 Td
(disk)Tj
1.8709 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(4)Tj
0 g
(].)Tj
1.2586 0 Td
(This)Tj
1.9899 0 Td
(can)Tj
1.6214 0 Td
(affect)Tj
2.3755 0 Td
(the)Tj
1.474 0 Td
(host's)Tj
2.4888 0 Td
(ability)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(effectively)Tj
4.2123 0 Td
(absorb)Tj
-34.0949 -1.2983 Td
(necessary)Tj
4.0195 0 Td
(nutrients)Tj
3.8664 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(Young)Tj
2.9027 0 Td
(children)Tj
3.5546 0 Td
(can)Tj
1.6271 0 Td
(suffer)Tj
2.4774 0 Td
(physical)Tj
3.4526 0 Td
(stunting)Tj
3.532 0 Td
(and)Tj
1.7348 0 Td
(wasting,)Tj
3.5036 0 Td
(cognitive)Tj
-32.2694 -1.2983 Td
(impairment,)Tj
5.21 0 Td
(and)Tj
1.7291 0 Td
(fine)Tj
1.7518 0 Td
(motor)Tj
2.7213 0 Td
(movement)Tj
4.5127 0 Td
(problems)Tj
3.9741 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(6)Tj
0 g
(].)Tj
1.2643 0 Td
(Food)Tj
2.2903 0 Td
(and)Tj
1.7292 0 Td
(Drug)Tj
2.3187 0 Td
(Administration)Tj
-28.7601 -1.3039 Td
(\(FDA\))Tj
2.8459 0 Td
(approved)Tj
3.9742 0 Td
(treatments)Tj
4.4957 0 Td
(for)Tj
1.389 0 Td
(giardiasis)Tj
3.9741 0 Td
(include)Tj
3.1861 0 Td
(metronidazole,)Tj
6.2305 0 Td
(chemically)Tj
4.4844 0 Td
(related)Tj
2.948 0 Td
(nitroimi-)Tj
-33.5279 -1.2983 Td
(dazole)Tj
2.7722 0 Td
(drugs,)Tj
2.6986 0 Td
(and)Tj
1.7291 0 Td
(albendazole.)Tj
5.1534 0 Td
(However,)Tj
4.0762 0 Td
(a)Tj
0.6576 0 Td
(substantial)Tj
4.5014 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0784 0 Td
(presentations)Tj
5.5786 0 Td
(are)Tj
-34.6788 -1.2982 Td
(resistant)Tj
3.5829 0 Td
(to)Tj
1.0262 0 Td
(these)Tj
2.2506 0 Td
(treatments)Tj
4.4958 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(8)Tj
0 g
(].)Tj
1.2586 0 Td
(A)Tj
0.9071 0 Td
(combined)Tj
4.2406 0 Td
(treatment)Tj
4.1385 0 Td
(regimen)Tj
3.5376 0 Td
(of)Tj
1.0148 0 Td
(metronidazole)Tj
6.0095 0 Td
(and)Tj
-33.7264 -1.3039 Td
(albendazole)Tj
4.9265 0 Td
(or)Tj
1.0999 0 Td
(quinacrine)Tj
4.541 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1452 0 Td
(highly)Tj
2.7099 0 Td
(effective)Tj
3.5093 0 Td
(for)Tj
1.3889 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9956 0 Td
(metronidazole-resis)Tj
7.9256 0 Td
(tant)Tj
-34.2366 -1.2983 Td
(giardiasis)Tj
3.9741 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(10)Tj
0 g
(])Tj
1.5137 0 Td
(but)Tj
1.5533 0 Td
(toxicity)Tj
3.2032 0 Td
(often)Tj
2.2847 0 Td
(limits)Tj
2.4774 0 Td
(therapy.)Tj
/F14 1 Tf
3.4753 0 Td
[()13(\n)-20()-13( )12()11()7()10( )4()11(\n)-9()4(\r)12()12()12()]TJ
/F9 1 Tf
6.8428 0 Td
(infections)Tj
4.1499 0 Td
(are)Tj
1.4513 0 Td
(chronic)Tj
3.2882 0 Td
(and,)Tj
-35.4725 -1.2983 Td
(in)Tj
1.0318 0 Td
(some)Tj
2.3357 0 Td
(cases,)Tj
2.4434 0 Td
(fatal)Tj
1.9219 0 Td
(in)Tj
1.0375 0 Td
(immune)Tj
3.6283 0 Td
(compromised)Tj
5.76 0 Td
(patients)Tj
3.3675 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
3.549 0 Td
(Infection)Tj
3.8607 0 Td
(is)Tj
0.8504 0 Td
(caused)Tj
2.9197 0 Td
(by)Tj
1.1792 0 Td
(ingestion)Tj
-33.8851 -1.3039 Td
(of)Tj
1.0147 0 Td
(environmentally)Tj
6.8088 0 Td
(resistant)Tj
3.583 0 Td
(infective)Tj
3.617 0 Td
(stages,)Tj
2.7893 0 Td
(called)Tj
2.5171 0 Td
(cysts)Tj
2.1203 0 Td
(\()Tj
/F14 1 Tf
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.4627 0 Td
[()4()16()17()10()12()4()]TJ
/F9 1 Tf
(\))Tj
3.5206 0 Td
(or)Tj
1.0998 0 Td
(oocysts)Tj
3.1294 0 Td
(\()Tj
/F14 1 Tf
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.4117 0 Td
[( )4()16(\n)-20()-13()12()]TJ
/F9 1 Tf
(\),)Tj
-33.0744 -1.2982 Td
(upon)Tj
2.3187 0 Td
(passage)Tj
3.2144 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(feces)Tj
2.1429 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.075 0 Td
(Ingestion)Tj
3.9798 0 Td
(of)Tj
1.0148 0 Td
(as)Tj
1.0148 0 Td
(few)Tj
1.6157 0 Td
(as)Tj
1.0148 0 Td
(10)Tj
1.1679 0 Td
(cysts)Tj
2.1203 0 Td
(or)Tj
1.0998 0 Td
(oocysts)Tj
3.1295 0 Td
(can)Tj
1.627 0 Td
(lead)Tj
1.8539 0 Td
(to)Tj
1.0261 0 Td
(clinical)Tj
3.0728 0 Td
(epi-)Tj
-35.9941 -1.2983 Td
(sodes)Tj
2.398 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
3.5433 0 Td
(Nitazoxanide)Tj
5.5446 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(only)Tj
1.9729 0 Td
(FDA-approved)Tj
6.2759 0 Td
(therapy)Tj
3.2428 0 Td
(for)Tj
1.3889 0 Td
(cryptosporidiosis.)Tj
7.3304 0 Td
(How-)Tj
-34.0155 -1.3039 Td
(ever,)Tj
2.1146 0 Td
(nitazoxanide)Tj
5.3574 0 Td
(has)Tj
1.5421 0 Td
(shown)Tj
2.8459 0 Td
(little)Tj
2.0013 0 Td
(efficacy)Tj
3.2201 0 Td
(in)Tj
1.0375 0 Td
(immunocompromised)Tj
9.2579 0 Td
(patients)Tj
3.3675 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(])Tj
1.8482 0 Td
(and)Tj
1.7291 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
-35.172 -1.2983 Td
(approved)Tj
3.9741 0 Td
(for)Tj
1.3833 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0375 0 Td
(children)Tj
3.5546 0 Td
(under)Tj
2.6192 0 Td
(the)Tj
1.4683 0 Td
(age)Tj
1.5421 0 Td
(of)Tj
1.0148 0 Td
(one)Tj
1.7007 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
2.075 0 Td
(Consequently,)Tj
5.9584 0 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(increasing)Tj
-32.173 -1.2983 Td
(need)Tj
2.1429 0 Td
(to)Tj
1.0262 0 Td
(develop)Tj
3.3165 0 Td
(alternative)Tj
4.422 0 Td
(drugs)Tj
2.4718 0 Td
(for)Tj
1.389 0 Td
(both)Tj
2.0579 0 Td
(cryptosporidiosis)Tj
7.1036 0 Td
(and)Tj
1.7348 0 Td
(giardiasis)Tj
3.9741 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
-28.4426 -1.2982 Td
(Methods)Tj
3.7587 0 Td
(to)Tj
1.0261 0 Td
(accelerate)Tj
4.1216 0 Td
(drug)Tj
2.1146 0 Td
(discovery)Tj
4.0082 0 Td
(by)Tj
1.1792 0 Td
(high-throughput)Tj
6.9278 0 Td
(screening)Tj
4.0535 0 Td
(of)Tj
1.0148 0 Td
(large)Tj
2.16 0 Td
(chemical)Tj
-31.5607 -1.3039 Td
(libraries)Tj
3.4695 0 Td
(will)Tj
1.6611 0 Td
(require)Tj
3.1124 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(assay)Tj
2.2677 0 Td
(platforms)Tj
4.0592 0 Td
(that)Tj
1.7801 0 Td
(provide)Tj
3.2882 0 Td
(reliability,)Tj
4.2293 0 Td
(sensitivity,)Tj
4.4447 0 Td
(have)Tj
-34.7355 -1.2983 Td
(easily)Tj
2.4037 0 Td
(observable)Tj
4.456 0 Td
(readouts,)Tj
3.8948 0 Td
(and)Tj
1.7292 0 Td
(are)Tj
1.4513 0 Td
(both)Tj
2.0579 0 Td
(cost)Tj
1.8142 0 Td
(and)Tj
1.7291 0 Td
(time)Tj
2.0296 0 Td
(efficient.)Tj
3.668 0 Td
(A)Tj
0.9071 0 Td
(bioluminescent)Tj
6.3892 0 Td
(assay)Tj
2.2621 0 Td
(that)Tj
-34.7922 -1.2983 Td
(fits)Tj
1.4343 0 Td
(these)Tj
2.2507 0 Td
(criteria)Tj
3.0784 0 Td
(for)Tj
1.3833 0 Td
(high-throughput)Tj
6.9278 0 Td
(drug)Tj
2.1146 0 Td
(screening)Tj
4.0536 0 Td
(of)Tj
1.0147 0 Td
(inhibitors)Tj
4.1386 0 Td
(against)Tj
/F14 1 Tf
3.0274 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.0715 0 Td
[( )4()16(\n)-20()-13()12()]TJ
/F9 1 Tf
3.2825 0 Td
(was)Tj
-33.7774 -1.3039 Td
(recently)Tj
3.4072 0 Td
(described)Tj
4.0535 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(23)Tj
0 g
(].)Tj
1.7404 0 Td
(Screening)Tj
4.1669 0 Td
(of)Tj
1.0148 0 Td
(molecules)Tj
4.1953 0 Td
(against)Tj
/F14 1 Tf
3.0274 0 Td
[()]TJ
/F9 1 Tf
(.)Tj
/F14 1 Tf
1.1225 0 Td
[()4()16()17()10()12()4()]TJ
/F9 1 Tf
3.1804 0 Td
(parasites)Tj
3.6907 0 Td
(traditionally)Tj
-31.3339 -1.2983 Td
(involved)Tj
3.651 0 Td
(microscopic)Tj
5.1023 0 Td
(counting)Tj
3.8097 0 Td
(of)Tj
1.0148 0 Td
(parasites)Tj
3.685 0 Td
([)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(],)Tj
2.0807 0 Td
(or)Tj
1.0941 0 Td
(utilizing)Tj
3.5206 0 Td
(a)Tj
0.6577 0 Td
(MOXI)Tj
2.8516 0 Td
(cell)Tj
1.559 0 Td
(coulter)Tj
3.0161 0 Td
(counter)Tj
3.3222 0 Td
([)Tj
0.83 0.64 0.02 0 k
(25)Tj
0 g
(],)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 263.7354 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Pathog)Tj
3.111 0 Td
(en)Tj
1.311 0 Td
(Box)Tj
1.9205 0 Td
(dual)Tj
2.0693 0 Td
(inhibitors)Tj
4.1386 0 Td
(effectiv)Tj
3.1111 0 Td
(e)Tj
0.7654 0 Td
(against)Tj
/F6 1 Tf
3.3874 0 Td
(Giardia)Tj
3.3803 0 Td
(lamblia)Tj
/F0 1 Tf
3.3237 0 Td
(and)Tj
/F6 1 Tf
1.8567 0 Td
(Cryptos)Tj
3.3874 0 Td
(poridium)Tj
3.9827 0 Td
(parvum)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00066)Tj
3.8197 0 Td
(73)Tj
0 g
2.0905 0 Td
(August)Tj
3.2882 0 Td
(6,)Tj
1.0418 0 Td
(2018)Tj
24.5978 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(16)Tj
/F11 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(R01HD08067)Tj
5.074 0 Td
(0.)Tj
0.9213 0 Td
(The)Tj
1.5874 0 Td
(funders)Tj
3.0473 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6086 0 Td
(in)Tj
0.893 0 Td
(study)Tj
-15.8883 -1.3748 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7418 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4087 0 Td
(decision)Tj
3.2953 0 Td
(to)Tj
-16.7245 -1.3749 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F10 1 Tf
-10.9063 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F11 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
BT
10.3394 77.8399 Td
(exist.)Tj
ET
Q
endstream
endobj
65 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 70 0 R/Contents 71 0 R/TrimBox[0 0 612 792]>>
endobj
69 0 obj
<>
endobj
72 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
1 beginbfchar
<010C><03B2>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
73 0 obj
<>/FontDescriptor 74 0 R/DW 250/W[268[495]]>>
endobj
74 0 obj
<>
endobj
75 0 obj
<>stream
cvt 0Y "fpgm2Msf bglyfX headZ8U 6hhea $hmtx
loca e
maxpx prep
y_<